Correlation of clinical and laboratory factors with fibrosis in nonalcoholic steatohepatitis

被引:0
|
作者
Lee, Tae Hoon [1 ]
Tekleyes, Fikadu [1 ]
Pacioles, Toni [1 ]
Shora, Waseem [1 ]
Ahmed, Monjur [1 ]
机构
[1] Marshall Univ, Huntington, WV USA
来源
关键词
D O I
10.14309/00000434-200809001-00419
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
419
引用
收藏
页码:S161 / S162
页数:2
相关论文
共 50 条
  • [41] Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)
    Wang, Z.
    Zhao, Z.
    Xia, Y.
    Cai, Z.
    Wang, C.
    Shen, Y.
    Liu, R.
    Qin, H.
    Jia, J.
    Yuan, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (07) : 1379 - 1392
  • [42] Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis
    Sachin Sharma
    Dounia Le Guillou
    Jennifer Y. Chen
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 662 - 678
  • [43] Serum markers of fibrogenesis and fibrosis in nonalcoholic steatohepatitis (NASH).
    Costanzo, M
    Miele, L
    Di Rocco, P
    Forgione, A
    Alfei, B
    Pompili, M
    Rapaccini, GL
    Grieco, A
    Gasbarrini, G
    HEPATOLOGY, 2002, 36 (04) : 412A - 412A
  • [44] Phosphoproteomic Biomarkers Predicting Histologic Nonalcoholic Steatohepatitis and Fibrosis
    Younossi, Zobair M.
    Baranova, Ancha
    Stepanova, Maria
    Page, Sandra
    Calvert, Valerie S.
    Afendy, Arian
    Goodman, Zachary
    Chandhoke, Vikas
    Liotta, Lance
    Petricoin, Emanuel
    JOURNAL OF PROTEOME RESEARCH, 2010, 9 (06) : 3218 - 3224
  • [45] Clinical and Histologic Characterization of Steatotic HCV Liver Biopsy: Central Portalization Correlates with Fibrosis but Not with Risk Factors for Nonalcoholic Steatohepatitis (NASH)
    Lee, H.
    Dresser, K.
    Kurian, E. M.
    MODERN PATHOLOGY, 2014, 27 : 424A - 424A
  • [46] Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis
    Chen, Hui
    Zhao, Wenshan
    Yan, Xuzhen
    Huang, Tao
    Yang, Aiting
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (04) : 577 - 588
  • [47] Liver fibrosis in the context of nonalcoholic steatohepatitis: the role of adipokines
    Di Maira, Giovanni
    Pastore, Mirella
    Marra, Fabio
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2018, 64 (01) : 39 - 50
  • [48] Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
    Munkhzul Ganbold
    Yohei Owada
    Yusuke Ozawa
    Yasuhiro Shimamoto
    Farhana Ferdousi
    Kenichi Tominaga
    Yun-Wen Zheng
    Nobuhiro Ohkohchi
    Hiroko Isoda
    Scientific Reports, 9
  • [49] PITAVASTATIN PREVENT FIBROSIS IN NONALCOHOLIC STEATOHEPATITIS MODEL RAT
    Miyaki, Tomokatsu
    Nojiri, Shunsuke
    Sugauchi, Fuminako
    Sakamoto, Tomoyuki
    Senda, Katsuhiro
    Joh, Takashi
    HEPATOLOGY, 2008, 48 (04) : 847A - 848A
  • [50] Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitis
    Iwaki, Michihiro
    Yoneda, Masato
    Wada, Naohiro
    Otani, Tomohiro
    Kobayashi, Takashi
    Nogami, Asako
    Saito, Satoru
    Nakajima, Atsushi
    EXPERT OPINION ON EMERGING DRUGS, 2024, 29 (02) : 127 - 137